| Product Code: ETC11626066 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Japan continued to import colorectal cancer drugs primarily from Germany, Switzerland, USA, Italy, and Metropolitan France. Despite a negative Compound Annual Growth Rate (CAGR) of -5.32% from 2020 to 2024, the market experienced a slightly less decline with a growth rate of -3.46% from 2023 to 2024. The Herfindahl-Hirschman Index (HHI) indicated low concentration among the top exporting countries, suggesting a diverse import market for colorectal cancer drugs in Japan. Monitoring these trends is crucial for stakeholders in the pharmaceutical industry to understand the evolving landscape and potential opportunities for growth.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Colorectal Cancer Drugs Therapeutic Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Colorectal Cancer Drugs Therapeutic Market - Industry Life Cycle |
3.4 Japan Colorectal Cancer Drugs Therapeutic Market - Porter's Five Forces |
3.5 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Colorectal Cancer Drugs Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of colorectal cancer in Japan |
4.2.2 Advancements in drug development and targeted therapies for colorectal cancer |
4.2.3 Growing awareness and screening programs for early detection of colorectal cancer |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for new colorectal cancer drugs in Japan |
4.3.2 High costs associated with innovative colorectal cancer drugs |
4.3.3 Competition from generic drug manufacturers impacting pricing and market share |
5 Japan Colorectal Cancer Drugs Therapeutic Market Trends |
6 Japan Colorectal Cancer Drugs Therapeutic Market, By Types |
6.1 Japan Colorectal Cancer Drugs Therapeutic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.4 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.5 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Japan Colorectal Cancer Drugs Therapeutic Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.2.5 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.2.6 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Japan Colorectal Cancer Drugs Therapeutic Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Japan Colorectal Cancer Drugs Therapeutic Market Import-Export Trade Statistics |
7.1 Japan Colorectal Cancer Drugs Therapeutic Market Export to Major Countries |
7.2 Japan Colorectal Cancer Drugs Therapeutic Market Imports from Major Countries |
8 Japan Colorectal Cancer Drugs Therapeutic Market Key Performance Indicators |
8.1 Patient survival rates post-treatment with colorectal cancer drugs |
8.2 Adoption rates of new colorectal cancer drugs in Japan |
8.3 Number of research studies and clinical trials focused on colorectal cancer drugs |
8.4 Investment in research and development by pharmaceutical companies for colorectal cancer drugs |
8.5 Patient adherence and compliance to prescribed colorectal cancer drug regimens |
9 Japan Colorectal Cancer Drugs Therapeutic Market - Opportunity Assessment |
9.1 Japan Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Japan Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Japan Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Colorectal Cancer Drugs Therapeutic Market - Competitive Landscape |
10.1 Japan Colorectal Cancer Drugs Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Japan Colorectal Cancer Drugs Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |